| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Roivant Sciences Ltd. Common Shares (NASDAQ: ROIV)
ROIV Technical Analysis
3
| As on 9th Jun 2023 ROIV STOCK Price closed @ 10.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.08 & Buy for SHORT-TERM with Stoploss of 7.85 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ROIVSTOCK Price
| Open | 9.63 | Change | Price | % |
| High | 10.12 | 1 Day | 0.45 | 4.70 |
| Low | 9.50 | 1 Week | 0.94 | 10.34 |
| Close | 10.03 | 1 Month | 1.60 | 18.98 |
| Volume | 6137500 | 1 Year | -2.43 | -19.50 |
| 52 Week High 13.52 | 52 Week Low 2.81 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ROIV Daily Charts |
ROIV Intraday Charts |
Whats New @ Bazaartrend |
ROIV Free Analysis |
|
|
ROIV Important Levels Intraday
| RESISTANCE | 11.22 |
| RESISTANCE | 10.84 |
| RESISTANCE | 10.60 |
| RESISTANCE | 10.37 |
| SUPPORT | 9.69 |
| SUPPORT | 9.46 |
| SUPPORT | 9.22 |
| SUPPORT | 8.84 |
ROIV Forecast May 2024
| 4th UP Forecast | 14.58 |
| 3rd UP Forecast | 13.12 |
| 2nd UP Forecast | 12.22 |
| 1st UP Forecast | 11.32 |
| 1st DOWN Forecast | 8.74 |
| 2nd DOWN Forecast | 7.84 |
| 3rd DOWN Forecast | 6.94 |
| 4th DOWN Forecast | 5.48 |
ROIV Weekly Forecast
| 4th UP Forecast | 15.77 |
| 3rd UP Forecast | 13.93 |
| 2nd UP Forecast | 12.79 |
| 1st UP Forecast | 11.65 |
| 1st DOWN Forecast | 8.41 |
| 2nd DOWN Forecast | 7.27 |
| 3rd DOWN Forecast | 6.13 |
| 4th DOWN Forecast | 4.29 |
ROIV Forecast2024
| 4th UP Forecast | 31.5 |
| 3rd UP Forecast | 24.61 |
| 2nd UP Forecast | 20.36 |
| 1st UP Forecast | 16.1 |
| 1st DOWN Forecast | 3.96 |
| 2nd DOWN Forecast | -0.3 |
| 3rd DOWN Forecast | -4.55 |
| 4th DOWN Forecast | -11.44 |
Roivant Sciences Ltd. Common Shares ( NASDAQ USA Symbol : ROIV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ROIV Business Profile
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service